Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Pharmaceutical Supply – Praziquantel and Pyrantel

Active

Federal

Response Deadline08/11/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract is for the supply of Praziquantel and Pyrantel in bulk tablet form, identified by NSN 6509015787110, ensuring full compliance with military and federal pharmaceutical standards. This procurement is issued as a subcontract under the Department of Defense, specifically managed by the Medical Supply Chain Pharm FSA, with performance required at APO 09227-0000. The solicitation was posted on August 5, 2026, and responses are due by August 11, 2026, with the NAICS code 325412 indicating classification under pharmaceutical and botanical manufacturing. The product must meet stringent quality and regulatory benchmarks to support military medical operations, and all deliveries are expected to adhere to the timelines and specifications outlined by the contracting authority.

General Info

Supply of Praziquantel and Pyrantel tablets to military standards, due August 11, 2026, NSN 6509015787110.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

APO, AE, 09227-0000, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 5

subcontract

Response DeadlineAug 11

Submission deadline

Response Deadline

08/11/2026, 05:00:00 PM UTCin 6 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Supply of Praziquantel and Pyrantel in bulk tablet form (NSN: 6509015787110) compliant with military and federal pharmaceutical standards.

Similar Contracts

Same NAICS industry code

ENROFLOXACIN INJECT

Solicitation # SPE2DP-26-T-4496

Enrofloxacin Injection, a veterinary antibiotic solution for dogs, is supplied at a concentration of 2.27% with a dosage of 2.5 mg per kilogram in a 20 mL volume, intended for intramuscular use in managing bacterial pathogens. The product is regulated by the FDA and requires strict adherence to shelf-life requirements, with a non-extendable shelf life of 24 months classified as a Type I (Code M) item. Storage must be maintained at or below 25 degrees Celsius with excursions permitted up to 40 degrees Celsius, and the product must be protected from direct sunlight and freezing. Packaging and marking must conform to the latest edition of the Medical Marking Standard No. 1, superseding all references to MIL-STD-129, and all units must be sealed in commercial containers designed to prevent damage and ensure safe transport. The item is procured under contract SPE2DP-26-T-4496 with a single unit of issue, delivered FOB destination within 81 days, with zero variance tolerance. Delivery is directed to the U.S. Medical Material Center in Kaiserslautern, Germany, with the required delivery date set for August 5, 2026. Supplier information includes Patterson Veterinary Supply, Inc. and Covetrus North America, LLC with designated part numbers, and all technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements. The contracting official must submit a referral via EBS for FDA-regulated product confirmation prior to award, including manufacturer and bidder details.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 12 hours ago

DEADLINE

NEOMYCIN AND POLYMYXIN

Solicitation # SPE2DP-26-T-4500

The contract covers the procurement of Neomycin and Polymyxin B Sulfates and Gramicidin, a regulated pharmaceutical product with NDC number 24208-0790-62, supplied by Bausch & Lomb Pharmaceuticals Division under the Veteran’s Health Joint Venture program. The item is classified as a TYPE I (CODE Q) with a strict non-extendable shelf life of 36 months, and all packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129. Each unit must be sealed in a protective container and shipped in commercial exterior packaging suitable for safe transport by common carrier at the lowest cost to the delivery point, with all markings adhering to DLA’s medical marking standards. The product is subject to FDA regulation, requiring contracting officials to verify its status via EBS referral prior to award. The delivery is FOB destination, with required shipment within five days of award, and no quantity variance is permitted. The contract includes the NSN 6505-01-143-4643 and references the DLA Master List of Technical and Quality Requirements for applicable specifications, with the solicitation number SPE2DP-26-T-4500 and response deadline set for August 11, 2026. The item is procured under the authorized unit of issue BT (10 mL), with a total quantity of 3 units, and performance is to occur at Fort Lewis, WA. The contract is governed under federal acquisition protocols, and supplier submissions must include detailed information on the bidder, manufacturer, part number, and product description. All packaging and labeling must meet DLA’s technical and quality standards as defined in their official documentation.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 12 hours ago

DEADLINE

BENZOCAINE ORAL TOPICA

Solicitation # SPE2DP-26-T-4499

BENZOCAINE ORAL TOPICAL GEL 20% in a 1 oz 28g unit is being procured under contract SPE2DP-26-T-4499 with a single unit of issue BT equivalent to 28 grams and a required delivery within 20 days FOB destination. The item is classified as a TYPE I medical product with a fixed 36-month non-extendable shelf life and must comply with all technical and quality specifications referenced in the DLA Master List of Technical and Quality Requirements. Packaging must meet commercial standards and adhere strictly to Medical Marking Standard No. 1 superseding MIL-STD-129, ensuring each unit is sealed in protective containment and shipped in appropriate exterior containers suitable for safe delivery via common carrier at the lowest cost. The product must be marked and documented in accordance with DLA medical standards and all applicable defense information security requirements. The manufacturer is BEUTLICH PHARMACEUTICALS LLC with NDC 00283-0871-31, and the NSN is 6505010645769 with zero variance allowed in quantity. Inspection and acceptance occur at the destination point, and the entire procurement is governed by DLA’s unit of issue guidelines as defined in their official documentation, with all packaging conforming to MIL-STD-2073-1E.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 12 hours ago

DEADLINE

PRAZIQUANTEL, PYRANT

Solicitation # SPE2DP-26-T-4495

This contract specifies the procurement of veterinary tablets containing 22.7 mg praziquantel, 22.7 mg pyrantel pamoate, and 113.4 mg febantel, intended for use in puppies or small dogs weighing at least 2 pounds and older than 3 weeks, to treat and control tapeworms, hookworms, and whipworms. The product is packaged in bottles of 50 tablets each, with a total of three bottles required under this solicitation. The item has a non-extendable shelf life of 36 months and must be stored at controlled room temperature. Packaging must comply with MIL-STD-2073-1E and Medical Marking Standard No. 1, superseding MIL-STD-129, with all units sealed and protected to prevent damage during transit. Delivery is required FOB destination within 81 days, to a specified military medical logistics center in Kaiserslautern, Germany, with the final destination being APO AE 09227-0000. The product is classified as hazardous material, requiring full compliance with OSHA’s Hazard Communication Standard, including the submission of Safety Data Sheets and compliant labels in accordance with 29 C.F.R. 1910.1200, along with employee training on these requirements. The procurement falls under NSN 6509-01-578-7110, with a unit price of $3.00 per bottle and a total contract value of $9.00. All supplies must be labeled and marked per government medical standards, and the supplier must adhere to the revised Federal Standard No. 313-E as of June 1, 2015, to ensure safety and regulatory compliance for government use.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 12 hours ago

DEADLINE

Neural Stem Cell (H9-scNSC) GMP Cell Bank SupplyThe contract entails the supply of a GMP-grade H9-scNSC Working Cell Bank specifically intended for use in grafting procedures, requiring strict adherence to current Good Manufacturing Practices to ensure product safety, purity, and consistency. The vendor is responsible for the full lifecycle management of the cell bank, including rigorous authentication to confirm cell line identity, comprehensive testing for microbial contamination and genetic stability, and proper cryopreservation with accompanying documentation that validates each step of the process. All deliverables must meet regulatory and quality standards appropriate for clinical applications. This subcontract is solicited by the Department of Veterans Affairs under the Rpo East (36C24E) office, with a North American Industry Classification System code of 325412, indicating focus on pharmaceutical and biological product manufacturing. The solicitation was posted on August 5, 2026, with responses due by August 10, 2026, allowing only a five-day window for qualified suppliers to submit proposals. The place of performance and specific location details are not provided, and no set-aside designation is specified, meaning all eligible contractors may respond. The contract is governed by regulatory compliance expectations typical for biologics intended for therapeutic use in human patients.

Rpo East (36C24E)

POSTED

about 17 hours ago

DEADLINE

6505--Supplies - Radioactive Isotopes - Ann Arbor

Solicitation # 36C25026Q0724_1

The U.S. Department of Veterans Affairs through the 250-NETWORK Contract Office 10 is soliciting offers for the supply of radioactive isotopes to support medical services at the Ann Arbor VA and Toledo CBOC under a full and open competition. The solicitation, numbered 36C25026Q0724_1, was posted on August 5, 2026, with proposals due by 3:00 p.m. Eastern Time on August 13, 2026. The contract falls under NAICS code 325412, which pertains to the manufacturing of radioactive radioisotopes, and is being procured through a combined solicitation requiring qualified vendors to respond with competitive pricing, technical compliance, and adherence to all regulatory and safety standards for handling and delivering radioactive materials. The contracting officer is Kellie Konopinski, reachable via phone at 734-222-4330 or email at kellie.konopinski@va.gov, and all correspondence must be directed through this point of contact. The place of performance is not explicitly defined in the provided details, but the supplies are intended for use at the Ann Arbor VA and Toledo CBOC facilities. The contract office is located in Dayton, Ohio, with a ZIP code of 45428, and all responses must comply with federal procurement regulations. There is no set-aside designation for small businesses or other categories, indicating the opportunity is open to all eligible contractors. The RFQ requires detailed technical and commercial proposals, including documentation of regulatory certifications, quality assurance protocols, and logistics capabilities to ensure timely delivery of isotopes under strict radiological safety conditions. The full requirements, including isotopes specifications, delivery schedules, packaging standards, and reporting obligations, are detailed in the attached RFQ document.

250-NETWORK Contract Office 10 (36C250)

POSTED

about 17 hours ago

DEADLINE

Pharmaceutical Packaging and Labeling ServicesThe contract requires the provision of compliant packaging and labeling services for Isoniazid tablets, adhering strictly to DLA, MIL-STD-129, and Medical Marking Standard No. 1 specifications. This subcontract is focused on ensuring all pharmaceutical packaging meets rigorous military and medical standards for identification, traceability, and handling, with performance location designated at Pearl Harbor, Hawaii, 96860-4518. The work must align with NAICS code 325412, which pertains to pharmaceutical preparation manufacturing, indicating a high level of regulatory and quality control expectation. The solicitation was posted on August 4, 2026, with a firm response deadline of August 10, 2026, and is managed by the Department of Defense through the Medical Supply Chain Pharm FSA. The contract emphasizes precision in labeling and packaging to support military medical logistics, requiring full compliance with federal standards for military distribution and inventory management. Failure to meet these requirements could result in rejection of deliverables, making adherence to technical specifications critical for successful performance.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Manufacturing of Disposable Heat Therapy PadsThe contract seeks full production of single-use heat therapy pads, encompassing the complete manufacturing process from chemical formulation to final sealing and military-compliant packaging. The work must adhere to strict defense standards, ensuring the product meets the operational and safety requirements of military use, with performance and delivery slated for Hurlbert Field, Florida, under the NAICS code 325412 for pharmaceutical and medicinal chemical manufacturing. All components and packaging must be designed to meet rigorous military specifications for durability, shelf life, and field readiness, with no room for deviation in quality or compliance. The opportunity is structured as a subcontract under the Department of Defense’s Medical Supply Chain FSH, with responses due by August 11, 2026, and the solicitation posted on August 4, 2026. Potential bidders must be prepared to demonstrate end-to-end capability in producing thermally active chemical systems that are safe, reliable, and packaged to withstand extreme conditions without compromising efficacy. There is no set-aside designation, indicating the contract is open to all eligible parties, and successful contractors will be expected to support immediate deployment needs within the defense medical logistics infrastructure.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Sterile Medical Supply Kit Assembly and PackagingThe contract involves the assembly and sterile packaging of pressure monitor kits containing critical medical components such as chambers, diaphragms, needles, gauges, and pre-filled syringes, specifically for military medical use. The work requires precise adherence to sterile manufacturing standards to ensure the safety and efficacy of the kits in field medical environments. All components must be integrated and sealed in a contamination-free environment to meet the demanding specifications of defense healthcare operations. The opportunity is structured as a subcontract with a response deadline of August 10, 2026, and is posted under NAICS code 325412, which classifies it under pharmaceutical and medicine manufacturing. The place of performance is designated as APO 09094-3219, indicating the work is to be executed in support of U.S. military operations overseas. The contracting entity is the Department of Defense through its Medical Supply Chain MD Surg FSF, and the submission portal is accessible via the DIBBS platform. There is no set-aside designation, meaning participation is open to all eligible subcontractors regardless of size or status.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

ISOPROPYL ALCOHOL

Solicitation # SPE2DP-26-T-4494

ISOPROPYL ALCOHOL USP, commonly known as rubbing alcohol, is a 99% isopropanol solution supplied in 473-milliliter bottles, equivalent to one pint or 16 ounces, and is classified as an over-the-counter product regulated by the FDA. It is highly flammable, poses serious eye irritation risks, and may cause drowsiness or dizziness, requiring storage at 20° to 25°C (68° to 77°F) away from heat, sparks, open flames, and hot surfaces with strict no-smoking protocols. The item is identified by NSN 6505-00-205-6513 and must comply with applicable hazardous materials regulations including 49 CFR and ICAO technical instructions. A current Material Safety Data Sheet (MSDS) is mandatory and must accompany each shipment, submitted electronically to DLA.MSDS@DLA.MIL alongside the required cover sheet P-75. Packaging must meet hazardous materials standards, and government identification must be removed from non-accepted supplies. This procurement is governed by DLA’s Master List of Technical and Quality Requirements, with the applicable revision determined by the solicitation or award date. The solicitation, issued under SPE2DP-26-T-4494 on August 4, 2026, with a response deadline of August 10, 2026, is for four bottles with a required delivery within five days to Pascagoula, Mississippi, under the NAICS code 325412, managed by the Department of Defense’s Medical Supply Chain Pharma FSA. All bidders must provide manufacturer details, part numbers, and item descriptions for FDA referral via EBS.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BUPIVACAINE AND EPINEP

Solicitation # SPE2DP-26-T-4478

The contract specifies the procurement of Bupivacaine and Epinephrine Injection, containing 0.500% w/v Bupivacaine HCl and 0.005 mg Epinephrine per mL (1:200,000), packaged in 1.8 mL cartridges, with a unit of issue of one case containing 50 cartridges. The product must be stored at controlled room temperature between 15 and 30 degrees Celsius and must have a minimum shelf life of 15 months at the time of delivery to the first government activity, despite an 18-month maximum shelf life. All packaging and labeling must comply with Medical Marking Standard No. 1, replacing MIL-STD-129, and must be commercially packaged to ensure safe transit under ASTM D3951 or applicable hazardous material standards if classified as hazardous under FED-STD-313. The supply must be free of intentional mercury or mercury compounds, except where functionally necessary and explicitly exempted, and any permitted mercury-containing components must meet Navy shockproof and secondary containment requirements. Delivery is required FOB destination within 20 days to the USS Delaware (SSN 791) at FPO AE 09583, with no variance allowed in quantity, and shipment must use traceable, expedited methods with no parcel post. The item is identified by NSN 6505-01-189-3973 and purchase request 7017729383, with a required delivery date of August 6, 2026. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, which supersedes any conflicting standards.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

VERAPAMIL HYDROCHLO

Solicitation # SPE2DP-26-T-4480

Verapamil Hydrochloride Extended-Release Tablets, 240 mg, are being procured in bottles of 100 tablets each, with a total quantity of two bottles required under contract SPE2DP-26-T-4480. The product must have a minimum of 31 months of shelf life remaining at the time of delivery, with a full 36-month shelf life specified and non-extendable. Packaging must comply strictly with DLA Packaging Requirements for Procurement and the latest Medical Marking Standard No. 1, superseding MIL-STD-129, and must ensure protection from damage during transit. All units must be commercially packaged in suitable exterior shipping containers, meeting the lowest freight rate standard for delivery to the specified destination. The item is regulated by the FDA, and the contracting official must confirm compliance via EBS referral. Manufacturer and distributor information includes Glenmark Pharmaceuticals Inc., USA and Cardinal Health 200, LLC, with the NDC number NDC68462-0260-01. The delivery is FOB destination, with a 20-day delivery window and no quantity variance permitted. Shipment must be traceable and cannot be sent via parcel post; instead, it must be transported using the FASTEST TRACEABLE MEANS with RDD 777 and referenced to the DLA vendor code V23027. The required delivery date is February 17, 2026, and the item is to be delivered to USS IWO JIMA LHD 7, FPO AA 34094. All packaging, labeling, and documentation must adhere to applicable DLA technical and quality requirements listed in the DLA Master List, which take precedence over ASTM D3951 and other commercial standards.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

MAROPITANT CITRATE

Solicitation # SPE2DP-26-T-4497

Maropitant Citrate is a veterinary pharmaceutical product supplied as 160mg tablets in blister packs containing four tablets per package, with the unit of issue being a single package of four tablets. The product must be stored at controlled room temperature between 20–25°C (68–77°F), with allowable excursions between 15–30°C (59–86°F). It has a non-extendable shelf life of 36 months and is classified as a Type I (Code Q) item under federal procurement standards. Packaging and marking must conform to the latest edition of the Medical Marking Standard No. 1, superseding all references to MIL-STD-129, and each unit must be sealed in a container that protects against damage during transit. The product is regulated by the FDA, and buyers are required to submit referrals via EBS to confirm product eligibility before procurement. The item is procured under solicitation SPE2DP-26-T-4497 with a delivery requirement of 88 days FOB destination, and no variance in quantity is permitted. Delivery must be made to a U.S. military medical logistics center in APO AE 09227-0000, with a specified shipping address in Kaiserslautern, Germany. Approved suppliers include Zoetis Inc., Patterson Veterinary Supply, Inc., and Covetrus North America, LLC, each with designated part numbers and NDC codes. All packaging must meet commercial standards and be suitable for safe transport by common carrier at the lowest cost.

All Other Health and Personal Care Retailers

POSTED

about 12 hours ago

DEADLINE

NIRMATRELVIR AND RI

Solicitation # SPE2DP-26-T-4498

The contract specifies the procurement of 50 boxes of PAXLOVID, each containing 10 blister cards with three tablets each—two 150 mg nirmatrelvir tablets and one 100 mg ritonavir tablet—providing a five-day course of treatment with two daily doses per box. The product is manufactured by Pfizer Inc under part number NDC00069-5321-30 and is regulated by the FDA, requiring confirmation via EBS referral. Each box constitutes a complete unit of issue, and the medication must be shipped within 20 days to the delivery point in Williamsburg, Virginia, with no variance allowed in quantity. The shelf life is fixed at 36 months and non-extendable, with packaging required to meet MIL-STD-2073-1E standards and medical marking Standard No. 1, superseding MIL-STD-129. All shipments must be traceable, cannot use parcel post, and must comply with DLA packaging and marking requirements. The contract is issued under solicitation SPE2DP-26-T-4498 with a response deadline of August 11, 2026, and an original required delivery date of April 28, 2026.

Medicinal and Botanical Manufacturing

POSTED

about 12 hours ago

DEADLINE

Palletization and DLA-Compliant Packaging ExecutionThe contract requires execution of palletization and packaging activities for pharmaceutical shipments in strict compliance with DLA RP001, ASTM D3951, and FED-STD-313 standards, ensuring all materials are handled and contained to meet federal military logistics requirements. The work must be performed at the designated place of performance in Pearl Harbor, Hawaii, with a zip code of 96860-4518, and is classified as a subcontract under NAICS code 423840, which pertains to wholesale trade of miscellaneous nondurable goods. The solicitation was posted on August 4, 2026, with a response deadline of August 10, 2026, providing a six-day window for submission. The contracting entity is the Department of Defense through the Medical Supply Chain Pharm FSA, indicating the critical nature of the shipments as part of defense medical logistics operations. All activities must adhere to rigorous regulatory frameworks to guarantee product integrity, safety, and readiness during transport and storage within the military supply chain.

Industrial Supplies Merchant Wholesalers

POSTED

DEADLINE

Radioactive or Mercury-Containing Item HandlingThe contract requires specialized handling and packaging of mercury-containing or radioactive materials in strict compliance with NAVSEA 5100-003D and MIL-STD-129 labeling standards, ensuring proper identification, containment, and documentation for safety and regulatory adherence. The work is to be performed at Pearl Harbor with a zip code of 96860-4518, and must meet all federal military specifications for the safe management of hazardous substances. This is a subcontract under the NAICS code 562910, which pertains to other waste management services, and is issued by the Department of Defense through the Medical Supply Chain Pharm FSA. The solicitation was posted on August 4, 2026, with a response deadline of August 10, 2026, indicating a tight turnaround for interested parties to submit their proposals. All activities under this contract must prioritize safety, regulatory compliance, and precise labeling as mandated by military standards to ensure secure handling and transport of hazardous materials within the defense supply chain.

Remediation Services

POSTED

DEADLINE

Specialized Transportation and Ocean Freight LogisticsThe contract requires specialized transportation and ocean freight logistics for the delivery of medical supplies under FOB destination terms, mandating the use of U.S.-flag vessels where applicable, ensuring compliance with U.S. maritime regulations. Advance coordination is essential to align shipping schedules and logistics planning, and all documentation must adhere to DFARS requirements to meet federal defense contracting standards. Performance is centered at Pearl Harbor, Hawaii, with the destination address indicating a critical hub for military medical supply distribution. The subcontract is issued under NAICS code 483111, classifying it as deep sea foreign freight transportation, and is managed by the Department of Defense’s Medical Supply Chain Pharm FSA. Response submissions are due by August 10, 2026, with solicitation materials accessible through the DIBBS system for qualified vendors to review and respond.

Deep Sea Freight Transportation

POSTED

DEADLINE

Hazardous and Shelf-Life Material Compliance ManagementThe contract requires comprehensive management of hazardous material compliance, specifically focusing on SDS submissions and OSHA hazard communication standards, ensuring all documentation and labeling are current and accurate as mandated by DLA RS001. It also entails strict tracking of a non-extendable 36-month shelf life for applicable materials, necessitating proactive monitoring, reporting, and disposition processes to prevent expiration and maintain regulatory adherence. Performance is mandated at Pearl Harbor, HI, with the work governed under the NAICS code 541690 for other scientific and technical consulting services, and the contract type is identified as a subcontract under the Department of Defense’s Medical Supply Chain Pharm FSA. Responses are due by August 10, 2026, and the solicitation was posted on August 4, 2026, indicating a narrow six-day window for submission.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE